questionsmedicales.fr
Métabolisme
Désalkylation
Désalkylation : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Désalkylation
Tests biochimiques
Anomalies hépatiques
Désalkylation
Imagerie médicale
Désalkylation
Enzymes hépatiques
Désalkylation
Symptômes
5
Nausées
Douleurs abdominales
Effets neurologiques
Désalkylation
Éruptions cutanées
Désalkylation
Hépatotoxicité
Désalkylation
Prévention
5
Prévention
Substances chimiques
Contrôles médicaux
Désalkylation
Éducation des patients
Médicaments
Mode de vie
Complications
Professionnels de santé
Interactions médicamenteuses
Traitements
5
Antidotes
Soins de soutien
Antiémétiques
Analgésiques
Prévention
Substances toxiques
Complications
5
Lésions hépatiques
Troubles neurologiques
Maladies chroniques
Cirrhose
Réversibilité
Traitement précoce
Surveillance clinique
Tests de laboratoire
Facteurs de risque
5
Facteurs de risque
Antécédents hépatiques
Habitudes alimentaires
Toxines
Tabagisme
Substances nocives
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Désalkylation : Questions médicales les plus fréquentes",
"headline": "Désalkylation : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Désalkylation : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-28",
"dateModified": "2025-02-22",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Désalkylation"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Métabolisme",
"url": "https://questionsmedicales.fr/mesh/D008660",
"about": {
"@type": "MedicalCondition",
"name": "Métabolisme",
"code": {
"@type": "MedicalCode",
"code": "D008660",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G03"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Déméthylation",
"alternateName": "Demethylation",
"url": "https://questionsmedicales.fr/mesh/D000073398",
"about": {
"@type": "MedicalCondition",
"name": "Déméthylation",
"code": {
"@type": "MedicalCode",
"code": "D000073398",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G03.219.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Déméthylation de l'ADN",
"alternateName": "DNA Demethylation",
"url": "https://questionsmedicales.fr/mesh/D000073399",
"about": {
"@type": "MedicalCondition",
"name": "Déméthylation de l'ADN",
"code": {
"@type": "MedicalCode",
"code": "D000073399",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G03.219.500.500"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Désalkylation",
"alternateName": "Dealkylation",
"code": {
"@type": "MedicalCode",
"code": "D003640",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Michael R Baldwin",
"url": "https://questionsmedicales.fr/author/Michael%20R%20Baldwin",
"affiliation": {
"@type": "Organization",
"name": "Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109-0600."
}
},
{
"@type": "Person",
"name": "Suzanne J Admiraal",
"url": "https://questionsmedicales.fr/author/Suzanne%20J%20Admiraal",
"affiliation": {
"@type": "Organization",
"name": "Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109-0600."
}
},
{
"@type": "Person",
"name": "Patrick J O'Brien",
"url": "https://questionsmedicales.fr/author/Patrick%20J%20O%27Brien",
"affiliation": {
"@type": "Organization",
"name": "Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109-0600. Electronic address: pjobrien@umich.edu."
}
},
{
"@type": "Person",
"name": "Yusuke Suzuki",
"url": "https://questionsmedicales.fr/author/Yusuke%20Suzuki",
"affiliation": {
"@type": "Organization",
"name": "Department of Hospital Pharmacy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Shizuoka, 431-3192, Japan."
}
},
{
"@type": "Person",
"name": "Takafumi Naito",
"url": "https://questionsmedicales.fr/author/Takafumi%20Naito",
"affiliation": {
"@type": "Organization",
"name": "Department of Hospital Pharmacy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Shizuoka, 431-3192, Japan. naitou@shinshu-u.ac.jp."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Paranoid thinking and perceived competitive intention.",
"datePublished": "2023-03-10",
"url": "https://questionsmedicales.fr/article/36923500",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7717/peerj.15003"
}
},
{
"@type": "ScholarlyArticle",
"name": "Rethinking paranoid ideation and reasoning: A pilot study based on the argumentative theory of reasoning.",
"datePublished": "2023-05-27",
"url": "https://questionsmedicales.fr/article/37307645",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jbtep.2023.101884"
}
},
{
"@type": "ScholarlyArticle",
"name": "Face Your Fears: Virtual reality-based cognitive behavioral therapy (VR-CBT) versus standard CBT for paranoid ideations in patients with schizophrenia spectrum disorders: a randomized clinical trial.",
"datePublished": "2022-08-15",
"url": "https://questionsmedicales.fr/article/35971137",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13063-022-06614-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Experimental studies of paranoid thinking in clinical and nonclinical populations: a systematic review and meta-analysis.",
"datePublished": "2023-07-10",
"url": "https://questionsmedicales.fr/article/37427557",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1017/S0033291723001708"
}
},
{
"@type": "ScholarlyArticle",
"name": "A randomised controlled test in virtual reality of the effects on paranoid thoughts of virtual humans' facial animation and expression.",
"datePublished": "2024-07-24",
"url": "https://questionsmedicales.fr/article/39048648",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-67534-4"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Métabolisme",
"item": "https://questionsmedicales.fr/mesh/D008660"
},
{
"@type": "ListItem",
"position": 3,
"name": "Désalkylation",
"item": "https://questionsmedicales.fr/mesh/D003640"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Désalkylation - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Désalkylation",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Désalkylation",
"description": "Comment diagnostiquer une désalkylation ?\nQuels tests sont utilisés pour la désalkylation ?\nQuels signes indiquent une désalkylation ?\nLa désalkylation est-elle détectable par imagerie ?\nQuels marqueurs sont associés à la désalkylation ?",
"url": "https://questionsmedicales.fr/mesh/D003640?mesh_terms=Paranoid+Disorders#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Désalkylation",
"description": "Quels symptômes sont liés à la désalkylation ?\nLa désalkylation provoque-t-elle des effets neurologiques ?\nY a-t-il des symptômes cutanés associés ?\nLa désalkylation affecte-t-elle le foie ?\nQuels signes de toxicité sont observés ?",
"url": "https://questionsmedicales.fr/mesh/D003640?mesh_terms=Paranoid+Disorders#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Désalkylation",
"description": "Comment prévenir la désalkylation ?\nLes contrôles médicaux aident-ils à prévenir la désalkylation ?\nL'éducation des patients est-elle importante ?\nLes changements de mode de vie aident-ils ?\nLes professionnels de santé jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D003640?mesh_terms=Paranoid+Disorders#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Désalkylation",
"description": "Quel traitement pour une désalkylation toxique ?\nLes médicaments peuvent-ils aider à la désalkylation ?\nComment gérer les symptômes de désalkylation ?\nY a-t-il des traitements préventifs ?\nLa désalkylation nécessite-t-elle une hospitalisation ?",
"url": "https://questionsmedicales.fr/mesh/D003640?mesh_terms=Paranoid+Disorders#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Désalkylation",
"description": "Quelles complications peuvent survenir ?\nLa désalkylation peut-elle entraîner des maladies chroniques ?\nY a-t-il des risques de surdosage ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications ?",
"url": "https://questionsmedicales.fr/mesh/D003640?mesh_terms=Paranoid+Disorders#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Désalkylation",
"description": "Quels sont les facteurs de risque de désalkylation ?\nL'âge influence-t-il le risque de désalkylation ?\nLes habitudes alimentaires affectent-elles le risque ?\nLe tabagisme est-il un facteur de risque ?\nLes maladies préexistantes influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D003640?mesh_terms=Paranoid+Disorders#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une désalkylation ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests biochimiques et des analyses de sang pour évaluer les métabolites."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour la désalkylation ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de toxicologie et des analyses enzymatiques sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une désalkylation ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes cliniques comme des anomalies hépatiques peuvent indiquer une désalkylation."
}
},
{
"@type": "Question",
"name": "La désalkylation est-elle détectable par imagerie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la désalkylation est généralement évaluée par des tests biochimiques, pas par imagerie."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont associés à la désalkylation ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les marqueurs comme les enzymes hépatiques peuvent être augmentés lors de la désalkylation."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à la désalkylation ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des nausées, des vomissements et des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "La désalkylation provoque-t-elle des effets neurologiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets neurologiques comme des vertiges peuvent survenir en cas de désalkylation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées peuvent apparaître en raison de réactions aux métabolites de désalkylation."
}
},
{
"@type": "Question",
"name": "La désalkylation affecte-t-elle le foie ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des anomalies hépatiques et une hépatotoxicité."
}
},
{
"@type": "Question",
"name": "Quels signes de toxicité sont observés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes de toxicité incluent fatigue, confusion et jaunisse dans les cas graves."
}
},
{
"@type": "Question",
"name": "Comment prévenir la désalkylation ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'exposition à des substances chimiques et suivre les prescriptions médicales aide."
}
},
{
"@type": "Question",
"name": "Les contrôles médicaux aident-ils à prévenir la désalkylation ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des contrôles réguliers peuvent détecter des problèmes avant qu'ils ne deviennent graves."
}
},
{
"@type": "Question",
"name": "L'éducation des patients est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, informer les patients sur les risques des médicaments et des toxines est crucial."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie aident-ils ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter un mode de vie sain peut réduire le risque de désalkylation et de complications."
}
},
{
"@type": "Question",
"name": "Les professionnels de santé jouent-ils un rôle ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les professionnels de santé doivent surveiller les interactions médicamenteuses et les risques."
}
},
{
"@type": "Question",
"name": "Quel traitement pour une désalkylation toxique ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des soins de soutien et des antidotes spécifiques selon le toxique."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider à la désalkylation ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent faciliter le métabolisme et l'élimination des toxines."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes de désalkylation ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des symptômes inclut des antiémétiques et des analgésiques pour le confort."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements préventifs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les substances toxiques et surveiller les médicaments peut prévenir la désalkylation."
}
},
{
"@type": "Question",
"name": "La désalkylation nécessite-t-elle une hospitalisation ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend de la gravité des symptômes et de l'exposition aux toxines, parfois nécessaire."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des lésions hépatiques, des troubles neurologiques et des réactions allergiques."
}
},
{
"@type": "Question",
"name": "La désalkylation peut-elle entraîner des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une désalkylation sévère peut contribuer à des maladies chroniques comme la cirrhose."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de surdosage ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un surdosage de substances pouvant subir désalkylation peut être fatal."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement précoce, d'autres non."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La surveillance clinique et les tests de laboratoire réguliers sont essentiels pour détecter les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de désalkylation ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'exposition à des toxines, l'usage de certains médicaments et des antécédents hépatiques."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de désalkylation ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent avoir un risque accru en raison d'une fonction hépatique diminuée."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires affectent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en toxines ou en médicaments peut augmenter le risque de désalkylation."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut augmenter le risque de désalkylation en raison de l'exposition à des substances nocives."
}
},
{
"@type": "Question",
"name": "Les maladies préexistantes influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme l'hépatite ou la cirrhose augmentent le risque de désalkylation."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 22/02/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109-0600.
Publications dans "Désalkylation" :
2 publications dans cette catégorie
Affiliations :
Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109-0600.
Publications dans "Désalkylation" :
2 publications dans cette catégorie
Affiliations :
Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109-0600. Electronic address: pjobrien@umich.edu.
Publications dans "Désalkylation" :
2 publications dans cette catégorie
Affiliations :
Department of Hospital Pharmacy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Shizuoka, 431-3192, Japan.
Publications dans "Désalkylation" :
2 publications dans cette catégorie
Affiliations :
Department of Hospital Pharmacy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Shizuoka, 431-3192, Japan. naitou@shinshu-u.ac.jp.
Department of Pharmacy, Shinshu University Hospital, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan. naitou@shinshu-u.ac.jp.
Publications dans "Désalkylation" :
2 publications dans cette catégorie
Affiliations :
Department of Hospital Pharmacy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Shizuoka, 431-3192, Japan.
Publications dans "Désalkylation" :
2 publications dans cette catégorie
Affiliations :
Department of Hospital Pharmacy, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Shizuoka, 431-3192, Japan.
Publications dans "Désalkylation" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, Texas A&M University, College Station, Texas 77843, United States.
Publications dans "Désalkylation" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, Texas A&M University, College Station, Texas 77843, United States.
Publications dans "Désalkylation" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, Texas A&M University, College Station, Texas 77843, United States.
Publications dans "Désalkylation" :
1 publication dans cette catégorie
Affiliations :
Kodikos Laboratories, Institut Cochin, Paris 75014, France.
Publications dans "Désalkylation" :
1 publication dans cette catégorie
Affiliations :
Kodikos Laboratories, Institut Cochin, Paris 75014, France.
Publications dans "Désalkylation" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, Texas A&M University, College Station, Texas 77843, United States.
Publications dans "Désalkylation" :
1 publication dans cette catégorie
Affiliations :
Department of Analytical Biochemistry, Groningen Research Institute of Pharmacy, University of Groningen, A Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Publications dans "Désalkylation" :
1 publication dans cette catégorie
Affiliations :
Department of Chemical Engineering, Engineering and Technology Institute Groningen, University of Groningen, 9747 AG, Groningen, The Netherlands.
Publications dans "Désalkylation" :
1 publication dans cette catégorie
Affiliations :
Department of Drug Design, University of Groningen, A Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Publications dans "Désalkylation" :
1 publication dans cette catégorie
Affiliations :
Department of Analytical Biochemistry, Groningen Research Institute of Pharmacy, University of Groningen, A Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Publications dans "Désalkylation" :
1 publication dans cette catégorie
Affiliations :
Department of Analytical Biochemistry, Groningen Research Institute of Pharmacy, University of Groningen, A Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Publications dans "Désalkylation" :
1 publication dans cette catégorie
Affiliations :
Department of Chemical Engineering, Engineering and Technology Institute Groningen, University of Groningen, 9747 AG, Groningen, The Netherlands.
Publications dans "Désalkylation" :
1 publication dans cette catégorie
Affiliations :
Department of Drug Design, University of Groningen, A Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Publications dans "Désalkylation" :
Paranoid thinking, that others are hostile, can be seen even in the general population. Paranoia is considered the expectation that others are competitors who aim to maximize the differences in payoff...
Cognitive theories assume an imbalance of intuitive and analytical reasoning in paranoid ideation. The argumentative theory of reasoning offers an approach on the primary function of reasoning and its...
327 participants completed the Social Network Index (SNI), the Paranoia Checklist (PCL), and the Cognitive Reflection Test-2 (CRT2). Moreover, preference and frequency of discussions were assessed. In...
The discussion group showed lower distorted reflective reasoning than the control group. Discussion preference and/or frequency was associated with frequency and disturbance of paranoid thoughts, as w...
Due to the online format environmental factors could not be held constant and no intrasubject comparison of the CRT2 could be computed in the trial. Furthermore, the sample mainly consisted of psychol...
The results contribute to the understanding of distorted reflective reasoning and provides preliminary evidence that the argumentative theory of reasoning may offer a promising perspective for delusio...
Schizophrenia spectrum disorders cause suffering for patients, relatives, and the surrounding society. Paranoid ideations, encompassing ideas of social reference and manifest persecutory delusions, ar...
This study is a randomized, assessor-blinded parallel-groups multi-center superiority clinical trial, fulfilling the CONSORT criteria for non-pharmacological treatment. A total of 256 patients diagnos...
The trial will elucidate whether VR-CBT can enhance therapy efficacy for paranoid ideations. Additionally, Trial findings will provide evidence on the effectiveness and cost-effectiveness of VR-CBT fo...
ClinicalTrials.gov NCT04902066 . Initial release April 9th, 2021....
Paranoia is common in clinical and nonclinical populations, consistent with continuum models of psychosis. A number of experimental studies have been conducted that attempt to induce, manipulate or me...
Virtual reality (VR) is increasingly used in the study and treatment of paranoia. This is based on the finding that people who mistakenly perceive hostile intent from other people also perceive simila...
Psychotic experiences have been associated with distortions in affective functioning, including aberrancies in affect dynamics. However, it remains unclear whether the two principal symptom dimensions...
Persecutory ideas are highly frequent in psychotic disorders and particularly in schizophrenia. Although several measures exist to assess persecutory ideas in both clinical and non-clinical samples, t...
100 individuals with schizophrenia and 72 non-clinical controls were recruited. We used the GPTS-8, a brief 8-item version of the R-GPTS recently developed and validated in the French general populati...
Confirmatory factor analysis supported the original two-factor structure (social reference and persecution subscales) of the GPTS-8. The GPTS-8 was positively and moderately correlated with the Positi...
The French GPTS 8-item brief scale-8 retains the psychometric strengths of the R-GPTS in schizophrenia with relevant clinical validity. The GPTS-8 can consequently be used as a short and quick measure...
Paranoia is a common and impairing psychosis symptom, which exists along a severity continuum that extends into the general population. Individuals at clinical high-risk for psychosis (CHR) frequently...
Participants were CHR individuals (n = 103), mixed clinical controls (n = 80), and healthy controls (n = 71) who completed self-report and interview measures. Confirmatory factor analysis (CFA), psych...
CFA replicated a two-factor structure for the RGPTS and the associated reference and persecution scales were reliable. CHR individuals scored significantly higher on both reference and persecution, re...
These results demonstrate the reliability and validity of the RGPTS, though its scales related more weakly to severity in CHR individuals. The RGPTS may be useful in future work aiming to develop symp...
Paranoia is the belief that others intend you harm. It is related to conspiracy theories, wherein those others represent an organized faction, coordinating the harm against self and others, and violat...
Cognitive Bias Modification for paranoia (CBM-pa) is a novel, theory-driven psychological intervention targeting the biased interpretation of emotional ambiguity associated with paranoia. Study object...
In a double-blind randomised controlled trial, sixty-three outpatients with clinically significant paranoia were randomised to either CBM-pa or an active control (text reading) between April 2016 and ...
A total of 122 patients were screened and 63 were randomised. The recruitment rate was 51.2%, with few dropouts (four out of 63) and follow-up rates were 90.5% (1-month) and 93.7% (3-months). Each ses...
CBM-pa is feasible for patients with paranoia. A fully powered randomised control trial is warranted....